Morphine market size?

There isn’t a single, widely cited “morphine market size” figure. Morphine is sold both as an active pharmaceutical ingredient (API) and in finished dosage forms, and the market size for each segment is typically reported only within broader opioid/analgesic markets. If you want a ballpark:

- Global morphine API market (raw material): roughly in the low hundreds of millions of USD per year. This segment is fairly small and highly regulated.
- Global finished-dose morphine market (injections, tablets, etc., used in hospitals and clinics): generally in the low billions USD per year, but highly regional and year-dependent due to supply constraints and regulatory controls.

These ranges can vary a lot by year, region (North America, Europe, Asia), and regulatory environment. For precise figures, it’s best to refer to market research reports that segment “morphine” within opioids/analgesics, such as those from IQVIA, Grand View Research, MarketsandMarkets, or Mordor Intelligence.

If you can specify:
- API vs. finished-dose market
- Region (global vs. specific regions)
- Timeframe (last 2–3 years vs. forecast)

I can give you more targeted ballpark numbers and point you to relevant sources. If you’d like, I can also help you outline a quick method to estimate the size using production volumes and assumed prices.